Saturday 17 October 2026
Export DVA’s income statement to Excel — free account
DaVita Inc.
DVA Healthcare Medical Care Facilities
DaVita Inc.’s revenue for fiscal 2025 (year ended December 2025) was $13.6 billion, up 6.46% from fiscal 2024. In the quarter to June 2026, revenue grew 5.17%, EPS grew 56.5%, free cash flow grew 49.4% and total debt rose 4.40%, each against the same quarter a year earlier. Member of the S&P 500; revenue growth for three consecutive years.
187.31
1.85
−0.98%
Follow DVA
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
14.96 | 20.67 | 61.26 | 13.95 | 18.23 | 12.26 | 12.52 | 14.05 | 13.56 | 11.23 |
Piotroski F-Score |
7 | 6 | 6 | 7 | 7 | 8 | 6 | 8 | 8 | 6 |
Altman Z-Score |
1.85 | 2.10 | 1.63 | 1.64 | 1.67 | 1.55 | 1.26 | 1.48 | 1.77 | 1.49 |
P/S ratio |
1.23 | 1.26 | 0.77 | 1.01 | 1.22 | 1.03 | 0.60 | 0.80 | 0.99 | 0.62 |
P/FCF ratio |
10.88 | 12.45 | 9.41 | 2.22 | 10.39 | 8.87 | 6.11 | 5.61 | 7.63 | 5.56 |
Altman Z″-Score (non-manufacturers) |
2.19 | 3.60 | 2.49 | 1.57 | 1.20 | 1.13 | 0.83 | 1.03 | 1.42 | 1.05 |
Beneish M-Score |
(2.81) | (2.66) | (2.57) | (2.61) | (2.72) | (2.71) | (2.65) | (2.86) | (2.70) | (2.59) |
P/Operating CF |
26.74 | 39.66 | 22.57 | 16.89 | 29.01 | 22.59 | 20.25 | 20.00 | 23.21 | 15.60 |
P/B ratio |
2.71 | 2.80 | 2.25 | 4.96 | 8.98 | 12.79 | 7.95 | 7.80 | 32.11 | 0.00 |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Sales |
1.98 | 2.07 | 1.62 | 1.61 | 1.87 | 1.75 | 1.33 | 1.45 | 1.66 | 1.33 |
EV/EBITDA |
7.73 | 8.67 | 8.73 | 8.14 | 9.30 | 8.19 | 7.47 | 7.50 | 7.54 | 6.57 |
EV/Operating CF |
10.77 | 11.74 | 10.43 | 8.87 | 10.93 | 10.51 | 9.89 | 8.56 | 10.50 | 9.61 |
EV/FCF |
17.61 | 20.44 | 19.79 | 3.55 | 15.98 | 15.05 | 13.58 | 10.18 | 12.74 | 11.94 |
Quick Ratio |
1.02 | 0.89 | 0.58 | 1.49 | 1.20 | 1.25 | 1.13 | 1.09 | 1.17 | 1.19 |
Current Ratio |
1.47 | 2.86 | 1.72 | 1.56 | 1.27 | 1.32 | 1.20 | 1.19 | 1.26 | 1.29 |
Net Debt/EBITDA |
2.95 | 3.39 | 4.57 | 3.05 | 3.25 | 3.36 | 4.11 | 3.37 | 3.03 | 3.51 |
Debt/Assets |
48.54% | 49.20% | 52.86% | 46.84% | 47.60% | 52.03% | 52.72% | 49.67% | 54.65% | 59.91% |
Debt/Equity |
1.88 | 1.91 | 2.58 | 3.50 | 5.16 | 9.52 | 10.19 | 6.75 | 23.86 | (28.02) |
Asset Turnover |
0.57 | 0.58 | 0.60 | 0.63 | 0.67 | 0.68 | 0.68 | 0.72 | 0.75 | 0.78 |
Operating CF/Net income |
2.24 | 2.88 | 11.11 | 2.56 | 2.56 | 1.97 | 2.79 | 2.98 | 2.16 | 2.53 |
Capex/Depreciation |
(1.06) | (1.05) | (1.42) | 5.06 | (0.99) | (0.85) | (0.66) | (0.68) | (0.70) | (0.76) |
| 17.71% | 13.63% | 3.62% | 26.04% | 39.82% | 78.19% | 61.85% | 65.24% | 114.19% | 6,746.19% | |
| 4.72% | 3.52% | 0.84% | 4.45% | 4.51% | 5.74% | 3.29% | 4.09% | 5.48% | 4.30% | |
ROIC |
9.78% | 8.29% | 7.02% | 11.16% | 11.60% | 12.12% | 8.92% | 10.94% | 14.66% | 13.71% |
Return on Tangible Assets |
21.21% | 7.50% | 2.30% | 16.93% | 18.44% | 23.03% | 14.78% | 19.37% | 25.21% | 20.03% |
Average Days of Receivables |
61.09 | 72.60 | 76.71 | 73.88 | 77.07 | 75.73 | 80.19 | 72.64 | 72.85 | 79.16 |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
10.02% | 9.78% | 9.96% | 9.69% | 10.80% | 10.29% | 11.67% | 12.14% | 12.00% | 12.27% |
Intangible Assets out of Total Assets |
0.32 | 0.35 | 0.36 | 0.40 | 0.42 | 0.42 | 0.43 | 0.43 | 0.44 | 0.44 |
Share Based Compensation of Revenue |
0.36% | 0.32% | 0.64% | 0.60% | 0.79% | 0.88% | 0.82% | 0.93% | 0.80% | 1.03% |
Graham Net Nets |
(0.76) | (0.39) | (0.77) | (0.98) | (0.87) | (1.09) | (1.85) | (1.29) | (1.03) | (1.64) |
Graham Number |
48.52 | 45.23 | 20.80 | 42.81 | 43.53 | 43.10 | 35.60 | 48.44 | 34.00 | 0.00 |
Earnings Yield |
6.68% | 4.84% | 1.63% | 7.17% | 5.49% | 8.16% | 7.99% | 7.12% | 7.38% | 8.91% |
Free Cash Flow Yield |
9.19% | 8.03% | 10.62% | 45.09% | 9.62% | 11.27% | 16.36% | 17.83% | 13.11% | 18.00% |
Revenue per Share |
53.10 | 57.66 | 66.78 | 74.35 | 96.42 | 110.41 | 124.85 | 133.72 | 150.79 | 183.80 |
Operating CF per Share |
9.78 | 10.14 | 10.37 | 13.53 | 16.52 | 18.35 | 16.82 | 22.68 | 23.79 | 25.42 |
Capex per Share |
(3.79) | (4.31) | (4.90) | 20.31 | (5.21) | (5.51) | (5.22) | (5.58) | (5.93) | (7.30) |
Free Cash Flow per Share |
5.99 | 5.83 | 5.47 | 33.84 | 11.31 | 12.84 | 11.60 | 17.10 | 17.86 | 18.12 |
Cash per Share |
4.87 | 2.93 | 2.45 | 7.97 | 4.36 | 5.49 | 4.48 | 5.25 | 10.95 | 10.54 |
Shareholders Equity per Share |
24.05 | 25.90 | 22.88 | 15.14 | 13.08 | 8.90 | 9.42 | 13.70 | 4.66 | (5.03) |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
24.05 | 25.90 | 22.88 | 15.14 | 13.08 | 8.90 | 9.42 | 13.70 | 4.66 | (5.03) |
Free Cash Flow |
1,207.76 | 1,100.25 | 934.71 | 5,183.20 | 1,354.63 | 1,350.88 | 1,078.72 | 1,552.27 | 1,518.32 | 1,344.81 |
Working Capital |
1,283.78 | 5,703.18 | 3,533.00 | 1,318.07 | 672.58 | 769.19 | 535.55 | 495.69 | 772.66 | 916.37 |
Capital Expenditures |
(764.37) | (812.91) | (836.93) | 3,110.85 | (624.40) | (580.00) | (485.85) | (506.76) | (503.72) | (541.69) |
Net Current Asset Value |
(9,911.29) | (5,317.77) | (6,777.69) | (11,301.98) | (12,273.04) | (13,017.62) | (12,897.07) | (12,511.61) | (13,143.33) | (13,795.83) |
EV/EBIT |
10.47 | 12.39 | 12.11 | 11.19 | 12.76 | 11.30 | 11.55 | 10.99 | 10.15 | 8.87 |
Capex to Sales |
0.07 | 0.07 | 0.07 | (0.27) | 0.05 | 0.05 | 0.04 | 0.04 | 0.04 | 0.04 |
Price to Operating Income |
6.47 | 7.55 | 5.76 | 6.99 | 8.30 | 6.66 | 5.20 | 6.05 | 6.08 | 4.13 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.25 | 0.25 | 0.17 | 0.18 | 0.18 | 0.20 | 0.23 | 0.24 | 0.25 | 0.25 |
Cash ROIC |
8.09% | 7.45% | 6.48% | 44.50% | 13.31% | 12.96% | 10.56% | 15.35% | 14.09% | 12.36% |
Accounts Receivable Turnover |
5.34 | 5.50 | 5.00 | 4.84 | 4.87 | 4.79 | 4.68 | 4.89 | 5.15 | 4.95 |
Accounts Payable Turnover |
15.31 | 15.82 | 16.86 | 18.25 | 19.06 | 19.07 | 18.62 | 16.73 | 16.20 | 14.87 |
Inventory Turnover |
42.96 | 44.65 | 56.68 | 77.09 | 76.24 | 72.79 | 75.82 | 65.97 | 61.93 | 62.63 |
Average Days of Payables |
22.43 | 24.32 | 20.63 | 18.62 | 19.84 | 18.41 | 21.33 | 22.57 | 23.23 | 27.49 |
Days of Inventory on Hand |
7.88 | 8.69 | 4.78 | 4.52 | 5.10 | 4.92 | 4.85 | 6.28 | 5.71 | 6.34 |
Average Receivables |
2,006.14 | 1,977.78 | 2,280.24 | 2,351.04 | 2,371.94 | 2,424.66 | 2,480.58 | 2,483.28 | 2,486.79 | 2,758.36 |
Average Payables |
485.28 | 482.87 | 486.19 | 433.56 | 419.05 | 418.15 | 440.91 | 497.16 | 530.87 | 621.67 |
Average Inventory |
173.00 | 171.11 | 144.59 | 102.67 | 104.79 | 109.53 | 108.28 | 126.11 | 138.83 | 147.59 |
Average Assets |
18,635.33 | 18,865.16 | 19,042.40 | 18,210.82 | 17,149.96 | 17,055.01 | 17,024.87 | 16,910.92 | 17,089.43 | 17,382.69 |
Average Common Equity |
4,966.96 | 4,867.90 | 4,397.23 | 3,113.82 | 1,943.00 | 1,251.45 | 906.02 | 1,059.98 | 819.97 | 11.07 |
Columns are period end dates